{
  "type": "hyp",
  "text": "Inhibition of NF-kappaB has been achieved by pharmacological and genetic approaches; however monocyte interactions with activated endothelium in shear flow following gene transfer of the NF-kappaB inhibitor IkappaB-alpha have not been studied. Inhibition of NF-kappaB has been achieved by pharmacological and genetic approaches; however monocyte interactions with activated endothelium in shear flow following gene transfer of the NF-kappaB inhibitor IkappaB-alpha have not been studied.\n",
  "self": {
    "NER": {
      "answers": [
        "NF",
        "NF-kappaB",
        "NF-kappaB"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What is the name of the protein that is able to inhibit kappaB?",
          "What is the main target of apoptosis?",
          "What is the main target of apoptosis?"
        ]
      }
    },
    "NOUN": {
      "answers": [
        "Inhibition",
        "NF-kappaB",
        "pharmacological and genetic approaches",
        "interactions",
        "activated endothelium",
        "shear flow",
        "gene transfer",
        "the NF-kappaB inhibitor",
        "IkappaB-alpha",
        "Inhibition",
        "NF-kappaB",
        "pharmacological and genetic approaches",
        "interactions",
        "activated endothelium",
        "shear flow",
        "gene transfer",
        "the NF-kappaB inhibitor",
        "IkappaB-alpha"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What is the main goal of a pharmacological approach to NF-kapp",
          "What is the main target of apoptosis?",
          "What is the method used to inhibit NF-kappaB?",
          "What has not been studied?",
          "What does the monocyte interact with?",
          "What is the process that causes monocyte interactions?",
          "What is the cause of the inactivation of NF-kappaB?",
          "What is the main cause of the reprogramming of the cytokine?",
          "What is the name of the NF-kappaB inhibitor?",
          "What is the main goal of a pharmacological approach to NF-kapp",
          "What is the main target of apoptosis?",
          "What is the method used to inhibit NF-kappaB?",
          "What has not been studied?",
          "What does the monocyte interact with?",
          "What is the process that causes monocyte interactions?",
          "What is the cause of the inactivation of NF-kappaB?",
          "What is the main cause of the reprogramming of the cytokine?",
          "What is the name of the NF-kappaB inhibitor?"
        ]
      }
    }
  },
  "asked": {
    "What might be relevant for designing future therapeutic strategies?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.00025576353073120117,
        "ground_truth": {
          "Findings": {
            "bertscore": 0.7192396521568298,
            "f1": 0
          }
        }
      }
    },
    "What promotes leukocyte-endothelium interaction?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0006946325302124023,
        "ground_truth": {
          "xenogeneic serum": {
            "bertscore": 0.6681813597679138,
            "f1": 0
          }
        }
      }
    },
    "What does xenogeneic serum promote?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 4.5299530029296875e-05,
        "ground_truth": {
          "leukocyte-endothelium interaction": {
            "bertscore": 0.5988408327102661,
            "f1": 0
          }
        }
      }
    },
    "What is the possible mechanism of leukocyte-endothelium interaction?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.005073904991149902,
        "ground_truth": {
          "NF-kappa B activation": {
            "bertscore": 0.6154857873916626,
            "f1": 0
          }
        }
      }
    },
    "What could the findings of xenogeneic serum be relevant for designing?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.000133514404296875,
        "ground_truth": {
          "future therapeutic strategies": {
            "bertscore": 0.6367928981781006,
            "f1": 0
          }
        }
      }
    },
    "What is the purpose of a xenogeneic serum study?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 8.749961853027344e-05,
        "ground_truth": {
          "xenograft survival": {
            "bertscore": 0.6740760207176208,
            "f1": 0
          }
        }
      }
    }
  }
}